ISIS

Isis Pharmaceuticals, Inc. Press Releases

$51.74
*  
0.17
0.33%
Get ISIS Alerts
*Delayed - data as of Sep. 4, 2015 12:44 ET  -  Find a broker to begin trading ISIS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ISIS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Isis Reports Financial Results And Highlights For Second Quarter 2015
8/4/2015 9:00:00 AM - PR Newswire
▼-0.12 % Price Change since this news event. The Volume Ratio is 1.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Isis Reports Positive Data from KYNAMRO® (mipomersen sodium) FOCUS FH Phase 3 Study in Patients with Severe Heterozygous Familial Hypercholesterolemia
8/3/2015 5:00:00 PM - PR Newswire
▼-4.54 % Price Change since this news event. The Volume Ratio is 1.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases
8/3/2015 2:00:00 AM - PR Newswire
▼-4.98 % Price Change since this news event. The Volume Ratio is 0.95.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Market Updates on Drug Manufacturers - Other Equities -- Isis Pharma, Endo Intl., Amarin, United Therapeutics, and POZEN
7/30/2015 9:10:00 AM - PR Newswire
▼-2.19 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine
7/29/2015 5:06:00 PM - PR Newswire
▼-2.29 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Webcast Alert: Isis Pharmaceuticals'' Second Quarter 2015 Financial Results Conference Call
7/28/2015 7:00:00 AM - PR Newswire
▼-4.19 % Price Change since this news event. The Volume Ratio is 1.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy
7/27/2015 7:00:00 AM - PR Newswire
▼-3.27 % Price Change since this news event. The Volume Ratio is 1.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet
7/22/2015 7:17:00 PM - PR Newswire
▼-6.64 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Isis Pharmaceuticals Initiates Clinical Study of ISIS-HTT Rx in Patients With Huntington''s Disease
7/21/2015 7:00:00 AM - PR Newswire
▼-7.08 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Garmin® Introduces Sport PRO™ Remote Trainer
7/20/2015 7:00:00 AM - Business Wire


Isis Pharmaceuticals Earns $2.15M For Advancing ISIS-SMN Rx in Children with Spinal Muscular Atrophy
7/14/2015 7:00:00 AM - PR Newswire
▼-3.79 % Price Change since this news event. The Volume Ratio is 1.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome
7/6/2015 7:00:00 AM - PR Newswire
▼-6.86 % Price Change since this news event. The Volume Ratio is 0.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting
6/30/2015 7:00:00 AM - PR Newswire
▼-8.12 % Price Change since this news event. The Volume Ratio is 1.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index
6/29/2015 2:41:00 PM - PR Newswire
▼-8.70 % Price Change since this news event. The Volume Ratio is 10.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Isis Pharmaceuticals Reports Data from ISIS-SMN Rx in Children with Spinal Muscular Atrophy
6/22/2015 7:00:00 AM - PR Newswire
▼-17.28 % Price Change since this news event. The Volume Ratio is 0.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Isis Pharmaceuticals to Present a General Corporate Update at its 2015 Annual Meeting of Stockholders and Open House
6/16/2015 7:00:00 AM - PR Newswire
▼-16.68 % Price Change since this news event. The Volume Ratio is 0.67.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Isis Pharmaceuticals Reports Data from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy
6/11/2015 7:00:00 AM - PR Newswire
▼-22.44 % Price Change since this news event. The Volume Ratio is 3.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Isis Pharmaceuticals to Host Webcast to Discuss Data From ISIS-SMN Rx Phase 2 Study in Infants With Spinal Muscular Atrophy
6/10/2015 5:30:00 PM - PR Newswire
▼-22.35 % Price Change since this news event. The Volume Ratio is 3.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day